Olema Pharmaceuticals (OLMA) Institutional Ownership

$10.79 -0.06 (-0.55%)

Closing price 08/27/2026 04:00 PM Eastern

Extended Trading

$11.14 +0.35 (+3.24%)

As of 08/27/2026 07:30 PM Eastern

Compare

Current Institutional Ownership Percentage: 91.78%
Number of Institutional Buyers (last 12 months): 119
Total Institutional Inflows (last 12 months): $935.39M

Number of Institutional Sellers (last 12 months): 36
Total Institutional Outflows (last 12 months): $156.05M

Get OLMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OLMA Institutional Buying and Selling by Quarter

Olema Pharmaceuticals Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	17,600	$220K	0.0%	N/A	0.020%
8/24/2026	California State Teachers Retirement System	732,285	$9.16M	0.0%	+1,773.9%	0.837%
8/23/2026	Readystate Asset Management LP	593,829	$7.43M	0.3%	N/A	0.679%
8/20/2026	Headlands Technologies LLC	41,242	$516K	0.1%	-30.5%	0.047%
8/20/2026	Susquehanna Fundamental Investments LLC	55,121	$690K	0.0%	N/A	0.063%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	49,136	$615K	0.0%	+96.3%	0.056%
8/19/2026	Wellington Management Group LLP	526,446	$6.59M	0.0%	-20.8%	0.602%
8/17/2026	Seven Fleet Capital Management LP	31,476	$394K	0.1%	N/A	0.036%
8/17/2026	Bank of America Corp DE	334,875	$4.19M	0.0%	N/A	0.383%
8/15/2026	Jupiter Topco LLC	7,094,413	$88.80M	0.0%	N/A	8.108%
Get the Latest News and Ratings for OLMA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
8/14/2026	Canada Pension Plan Investment Board	11,500	$144K	0.0%	N/A	0.013%
8/14/2026	Legal & General Group Plc	37,540	$470K	0.0%	N/A	0.043%
8/14/2026	The Manufacturers Life Insurance Company	89,990	$1.13M	0.0%	N/A	0.103%
8/14/2026	Algert Global LLC	80,928	$1.01M	0.0%	+125.6%	0.092%
8/13/2026	Portland Investment Counsel Inc.	50,000	$626K	0.2%	N/A	0.057%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	66,163	$828K	0.0%	N/A	0.076%
8/12/2026	Quantbot Technologies LP	6,116	$77K	0.0%	N/A	0.007%
8/11/2026	E Fund Management Co. Ltd.	10,649	$133K	0.0%	N/A	0.012%
8/7/2026	BlackRock Inc.	6,714,691	$84.00M	0.0%	N/A	7.687%
8/7/2026	Deutsche Bank AG	95,834	$1.20M	0.0%	N/A	0.110%
8/6/2026	Bank of New York Mellon Corp	222,177	$2.78M	0.0%	N/A	0.254%
7/9/2026	Hennion & Walsh Asset Management Inc.	420,211	$5.26M	0.1%	-12.7%	0.481%
6/12/2026	Defilade Capital Management L.P.	1,504,536	$22.43M	3.1%	+21.9%	1.722%
5/19/2026	Bank of America Corp DE	508,706	$7.59M	0.0%	+112.9%	0.582%
5/19/2026	Janus Henderson Group PLC	7,108,488	$106.01M	0.1%	+5.9%	8.138%
5/18/2026	California State Teachers Retirement System	39,079	$583K	0.0%	+966.0%	0.045%
5/18/2026	Rock Springs Capital Management LP	170,378	$2.54M	0.1%	+73.4%	0.195%
5/16/2026	The Manufacturers Life Insurance Company	109,582	$1.63M	0.0%	+7.1%	0.125%
5/16/2026	Quantinno Capital Management LP	95,336	$1.42M	0.0%	+55.5%	0.109%
5/15/2026	Aristotle Atlantic Partners LLC	24,953	$372K	0.0%	N/A	0.029%
5/15/2026	Entropy Technologies LP	15,773	$235K	0.0%	-8.8%	0.018%
5/14/2026	Siren L.L.C.	4,756,949	$70.93M	2.0%	+44.1%	5.446%
5/14/2026	State of Wyoming	2,243	$33K	0.0%	-52.0%	0.003%
5/7/2026	Dimensional Fund Advisors LP	1,082,434	$16.13M	0.0%	+12.9%	1.239%
5/7/2026	SEB Asset Management AB	339,461	$5.06M	0.0%	N/A	0.389%
5/7/2026	Swiss National Bank	74,600	$1.11M	0.0%	N/A	0.085%
5/6/2026	Jennison Associates LLC	1,822,123	$27.17M	0.0%	+89.0%	2.086%
5/5/2026	Bank of New York Mellon Corp	193,483	$2.89M	0.0%	+9.8%	0.222%
5/1/2026	Candriam S.C.A.	759,513	$11.32M	0.1%	+11.8%	0.871%
4/27/2026	Y Intercept Hong Kong Ltd	90,375	$1.35M	0.0%	+143.0%	0.104%
It’s not about Greenland (Ad) The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar. Watch the full documentary before December's economic summit in Miami
4/27/2026	Fideuram Intesa Sanpaolo Private Banking S.P.A.	116,812	$1.74M	0.1%	+3,237.5%	0.134%
4/22/2026	Pictet Asset Management Holding SA	217,023	$3.24M	0.0%	-56.8%	0.249%
4/22/2026	Sterling Capital Management LLC	2,314	$35K	0.0%	-32.8%	0.003%
2/23/2026	Virtu Financial LLC	42,437	$1.06M	0.0%	N/A	0.062%
2/19/2026	Invesco Ltd.	155,732	$3.89M	0.0%	+25.0%	0.227%
2/18/2026	EP Wealth Advisors LLC	10,009	$250K	0.0%	N/A	0.015%
2/18/2026	Vestal Point Capital LP	1,650,000	$41.25M	1.4%	N/A	2.403%
2/18/2026	Virtus Investment Advisers LLC	8,049	$201K	0.1%	-71.3%	0.012%
2/18/2026	Wellington Management Group LLP	220,971	$5.52M	0.0%	+8.2%	0.322%
2/18/2026	Perceptive Advisors LLC	165,713	$4.14M	0.1%	N/A	0.241%
2/18/2026	Millennium Management LLC	498,490	$12.46M	0.0%	+50.4%	0.726%
2/18/2026	Ishara Investments LP	30,000	$750K	0.9%	N/A	0.044%
2/18/2026	Janus Henderson Group PLC	6,710,194	$167.90M	0.1%	+87.1%	9.773%
2/18/2026	Engineers Gate Manager LP	26,207	$655K	0.0%	N/A	0.038%
2/18/2026	Catalio Capital Management LP	267,058	$6.68M	1.2%	N/A	0.389%
2/18/2026	Cormorant Asset Management LP	2,750,000	$68.75M	3.2%	N/A	4.005%
2/18/2026	Balyasny Asset Management L.P.	167,308	$4.18M	0.0%	-75.9%	0.244%
2/18/2026	Bridgeway Capital Management LLC	40,500	$1.01M	0.0%	-42.1%	0.059%
2/18/2026	ACT Capital Management LLC	53,500	$1.34M	1.1%	N/A	0.078%
2/17/2026	ADAR1 Capital Management LLC	81,399	$2.04M	0.1%	+33.0%	0.119%
2/17/2026	Schonfeld Strategic Advisors LLC	113,978	$2.85M	0.0%	N/A	0.166%
2/17/2026	Burkehill Global Management LP	125,000	$3.13M	0.2%	N/A	0.182%
2/17/2026	PDT Partners LLC	27,368	$684K	0.0%	+78.9%	0.040%
2/17/2026	Cetera Investment Advisers	10,500	$262K	0.0%	N/A	0.015%
2/17/2026	Jain Global LLC	30,160	$754K	0.0%	N/A	0.044%
2/17/2026	RA Capital Management L.P.	2,600,000	$65M	0.7%	N/A	3.787%
2/17/2026	Bain Capital Life Sciences Investors LLC	8,508,641	$212.72M	16.3%	+24.3%	12.392%
2/17/2026	Paradigm Biocapital Advisors LP	7,544,172	$188.60M	4.8%	+11.0%	10.988%
2/17/2026	Trexquant Investment LP	49,754	$1.24M	0.0%	N/A	0.072%
2/17/2026	Jump Financial LLC	100,274	$2.51M	0.0%	N/A	0.146%
2/17/2026	Price T Rowe Associates Inc. MD	1,096,035	$27.40M	0.0%	+3,348.7%	1.596%
2/17/2026	Rock Springs Capital Management LP	98,240	$2.46M	0.1%	N/A	0.143%
2/17/2026	Adage Capital Partners GP L.L.C.	210,000	$5.25M	0.0%	N/A	0.306%
2/17/2026	Russell Investments Group Ltd.	4,735	$118K	0.0%	-12.3%	0.007%
2/17/2026	State of Wisconsin Investment Board	34,940	$874K	0.0%	N/A	0.051%
2/17/2026	Fred Alger Management LLC	64,484	$1.61M	0.0%	N/A	0.094%
2/17/2026	ExodusPoint Capital Management LP	150,670	$3.77M	0.0%	N/A	0.219%
2/17/2026	Royal Bank of Canada	6,700	$167K	0.0%	-95.5%	0.010%
2/17/2026	Polar Capital Holdings Plc	1,380,450	$34.51M	0.1%	N/A	2.011%
2/16/2026	Squarepoint Ops LLC	328,680	$8.22M	0.0%	+2,232.6%	0.479%
2/16/2026	Verition Fund Management LLC	33,382	$835K	0.0%	N/A	0.049%
2/16/2026	Nicholas Investment Partners LP	64,757	$1.62M	0.1%	N/A	0.094%
2/16/2026	First Turn Management LLC	617,714	$15.44M	1.8%	N/A	0.900%
2/16/2026	Eventide Asset Management LLC	569,000	$14.23M	0.2%	N/A	0.829%
2/16/2026	Entropy Technologies LP	17,304	$433K	0.0%	N/A	0.025%
2/16/2026	Barclays PLC	133,125	$3.33M	0.0%	+27.2%	0.194%
2/13/2026	Marshall Wace LLP	360,394	$9.01M	0.0%	N/A	0.525%
2/13/2026	The Manufacturers Life Insurance Company	102,322	$2.56M	0.0%	+398.1%	0.149%
2/13/2026	Quarry LP	3,001	$75K	0.0%	-84.0%	0.004%
2/13/2026	Vivo Capital LLC	671,843	$16.80M	1.1%	-55.4%	0.979%
It’s not about Greenland (Ad) The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar. Watch the full documentary before December's economic summit in Miami
2/13/2026	Rafferty Asset Management LLC	45,005	$1.13M	0.0%	N/A	0.066%
2/13/2026	Birchview Capital LP	269,000	$6.73M	3.9%	+54.6%	0.392%
2/13/2026	Siren L.L.C.	3,300,700	$82.52M	2.5%	N/A	4.807%
2/13/2026	Charles Schwab Investment Management Inc.	407,141	$10.18M	0.0%	+3.0%	0.593%
2/13/2026	State Street Corp	1,884,399	$47.11M	0.0%	+72.3%	2.745%
2/13/2026	Wells Fargo & Company MN	84,130	$2.10M	0.0%	+84.2%	0.123%
2/13/2026	Wealthspire Advisors LLC	10,172	$254K	0.0%	N/A	0.015%
2/12/2026	Empire Financial Management Company LLC	25,000	$625K	0.1%	N/A	0.036%
2/12/2026	HRT Financial LP	40,266	$1.01M	0.0%	+147.2%	0.059%
2/12/2026	MetLife Investment Management LLC	33,500	$838K	0.0%	-11.0%	0.049%

OLMA Institutional Ownership - Frequently Asked Questions

During the previous two years, 194 institutional investors and hedge funds held shares of Olema Pharmaceuticals. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($212.72M), Paradigm Biocapital Advisors LP ($188.60M), Janus Henderson Group PLC ($106.01M), Vanguard Group Inc. ($89.03M), Jupiter Topco LLC ($88.80M), BlackRock Inc. ($84.00M), and Siren L.L.C. ($70.93M).Learn more on Olema Pharmaceuticals' institutional investors.

91.78% of Olema Pharmaceuticals' stock is owned by institutional investors. Learn more on OLMA's institutional investor holdings.

Of the 177 institutional investors that purchased Olema Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bain Capital Life Sciences Investors LLC ($9.13M), Jupiter Topco LLC ($7.09M), BlackRock Inc. ($6.71M), Siren L.L.C. ($4.76M), Janus Henderson Group PLC ($3.52M), Cormorant Asset Management LP ($2.75M), and RA Capital Management L.P. ($2.60M).

Institutional investors have bought a total of 48,402,346 shares in the last 24 months. This purchase volume represents approximately $935.39M in transactions.

Of the 36 institutional investors that sold Olema Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Pictet Asset Management Holding SA ($1.42M), Woodline Partners LP ($1.29M), UBS Group AG ($1.12M), Millennium Management LLC ($939.64K), Vivo Capital LLC ($834.02K), Pier Capital LLC ($630.97K), and Franklin Resources Inc. ($535.30K).

Institutional investors have sold a total of 8,343,753 shares in the last 24 months. This volume of shares sold represents approximately $156.05M in transactions.

Related Companies

Institutional ownership data for NASDAQ:OLMA is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/25/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Olema Pharmaceuticals (OLMA) Institutional Ownership

OLMA Institutional Buying and Selling by Quarter

Olema Pharmaceuticals Major Shareholders & Ownership History

OLMA Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Olema Pharmaceuticals (OLMA) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Olema Pharmaceuticals (NASDAQ:OLMA)

OLMA Institutional Buying and Selling by Quarter

Olema Pharmaceuticals Major Shareholders & Ownership History

OLMA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OLMA shares?

What percentage of Olema Pharmaceuticals' stock is owned by institutional investors?

Which institutional investors have been buying Olema Pharmaceuticals' stock?

How much institutional buying is happening at Olema Pharmaceuticals?

Which of Olema Pharmaceuticals' major shareholders have been selling company stock?

How much institutional selling is happening at Olema Pharmaceuticals?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools